UK Litigation Roundup: Here's What You Missed In London

This past week in London has seen the U.S. Securities and Exchange Commission target a British investor over a $10 million microcap fraud scheme, Merck Sharp & Dohme move against Halozyme...

Already a subscriber? Click here to view full article